Literature DB >> 29850888

Mutation-specific effects in germline transmission of pathogenic mtDNA variants.

Auke B C Otten1, Suzanne C E H Sallevelt2, Phillippa J Carling3, Joseph C F M Dreesen2, Marion Drüsedau2, Sabine Spierts2, Aimee D C Paulussen2, Christine E M de Die-Smulders2, Mary Herbert4, Patrick F Chinnery5,6, David C Samuels7, Patrick Lindsey1, Hubert J M Smeets1.   

Abstract

STUDY QUESTION: Does germline selection (besides random genetic drift) play a role during the transmission of heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutations in humans? SUMMARY ANSWER: We conclude that inheritance of mtDNA is mutation-specific and governed by a combination of random genetic drift and negative and/or positive selection. WHAT IS KNOWN ALREADY: mtDNA inherits maternally through a genetic bottleneck, but the underlying mechanisms are largely unknown. Although random genetic drift is recognized as an important mechanism, selection mechanisms are thought to play a role as well. STUDY DESIGN, SIZE, DURATION: We determined the mtDNA mutation loads in 160 available oocytes, zygotes, and blastomeres of five carriers of the m.3243A>G mutation, one carrier of the m.8993T>G mutation, and one carrier of the m.14487T>C mutation. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Mutation loads were determined in PGD samples using PCR assays and analysed mathematically to test for random sampling effects. In addition, a meta-analysis has been performed on mutation load transmission data in the literature to confirm the results of the PGD samples. MAIN RESULTS AND THE ROLE OF CHANCE: By applying the Kimura distribution, which assumes random mechanisms, we found that mtDNA segregations patterns could be explained by variable bottleneck sizes among all our carriers (moment estimates ranging from 10 to 145). Marked differences in the bottleneck size would determine the probability that a carrier produces offspring with mutations markedly different than her own. We investigated whether bottleneck sizes might also be influenced by non-random mechanisms. We noted a consistent absence of high mutation loads in all our m.3243A>G carriers, indicating non-random events. To test this, we fitted a standard and a truncated Kimura distribution to the m.3243A>G segregation data. A Kimura distribution truncated at 76.5% heteroplasmy has a significantly better fit (P-value = 0.005) than the standard Kimura distribution. For the m.8993T>G mutation, we suspect a skewed mutation load distribution in the offspring. To test this hypothesis, we performed a meta-analysis on published blood mutation levels of offspring-mother (O-M) transmission for the m.3243A>G and m.8993T>G mutations. This analysis revealed some evidence that the O-M ratios for the m.8993T>G mutation are different from zero (P-value <0.001), while for the m.3243A>G mutation there was little evidence that the O-M ratios are non-zero. Lastly, for the m.14487T>G mutation, where the whole range of mutation loads was represented, we found no indications for selective events during its transmission. LARGE SCALE DATA: All data are included in the Results section of this article. LIMITATIONS, REASON FOR CAUTION: The availability of human material for the mutations is scarce, requiring additional samples to confirm our findings. WIDER IMPLICATIONS OF THE
FINDINGS: Our data show that non-random mechanisms are involved during mtDNA segregation. We aimed to provide the mechanisms underlying these selection events. One explanation for selection against high m.3243A>G mutation loads could be, as previously reported, a pronounced oxidative phosphorylation (OXPHOS) deficiency at high mutation loads, which prohibits oogenesis (e.g. progression through meiosis). No maximum mutation loads of the m.8993T>G mutation seem to exist, as the OXPHOS deficiency is less severe, even at levels close to 100%. In contrast, high mutation loads seem to be favoured, probably because they lead to an increased mitochondrial membrane potential (MMP), a hallmark on which healthy mitochondria are being selected. This hypothesis could provide a possible explanation for the skewed segregation pattern observed. Our findings are corroborated by the segregation pattern of the m.14487T>C mutation, which does not affect OXPHOS and MMP significantly, and its transmission is therefore predominantly determined by random genetic drift. Our conclusion is that mutation-specific selection mechanisms occur during mtDNA inheritance, which has implications for PGD and mitochondrial replacement therapy. STUDY FUNDING/COMPETING INTEREST(S): This work has been funded by GROW-School of Oncology and Developmental Biology. The authors declare no competing interests.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29850888      PMCID: PMC6551225          DOI: 10.1093/humrep/dey114

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  72 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.

Authors:  S L White; S Shanske; J J McGill; H Mountain; M T Geraghty; S DiMauro; H H Dahl; D R Thorburn
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

3.  Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA.

Authors:  S L White; S Shanske; I Biros; L Warwick; H M Dahl; D R Thorburn; S Di Mauro
Journal:  Prenat Diagn       Date:  1999-12       Impact factor: 3.050

4.  Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene.

Authors:  G Manfredi; N Gupta; M E Vazquez-Memije; J E Sadlock; A Spinazzola; D C De Vivo; E A Schon
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

Review 5.  Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.

Authors:  E Fosslien
Journal:  Ann Clin Lab Sci       Date:  2001-01       Impact factor: 1.256

6.  Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human rho degrees cell lines is associated either with selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNA.

Authors:  L Vergani; R Rossi; C H Brierley; M Hanna; I J Holt
Journal:  Hum Mol Genet       Date:  1999-09       Impact factor: 6.150

7.  Random genetic drift determines the level of mutant mtDNA in human primary oocytes.

Authors:  D T Brown; D C Samuels; E M Michael; D M Turnbull; P F Chinnery
Journal:  Am J Hum Genet       Date:  2000-12-29       Impact factor: 11.025

Review 8.  Towards reliable prenatal diagnosis of mtDNA point mutations: studies of nt8993 mutations in oocytes, fetal tissues, children and adults.

Authors:  H H Dahl; D R Thorburn; S L White
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

9.  The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both?

Authors:  P F Chinnery; D R Thorburn; D C Samuels; S L White; H M Dahl; D M Turnbull; R N Lightowlers; N Howell
Journal:  Trends Genet       Date:  2000-11       Impact factor: 11.639

10.  Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene.

Authors:  L G Nijtmans; N S Henderson; G Attardi; I J Holt
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

View more
  10 in total

1.  Mitochondrial donation: is Australia ready?

Authors:  Marie A Dziadek; Carolyn M Sue
Journal:  Med J Aust       Date:  2021-10-31       Impact factor: 12.776

2.  Comprehensive mitochondrial DNA analysis and IVF outcome.

Authors:  B Lledo; J A Ortiz; R Morales; E García-Hernández; J Ten; A Bernabeu; J Llácer; R Bernabeu
Journal:  Hum Reprod Open       Date:  2018-12-20

Review 3.  Evolving mtDNA populations within cells.

Authors:  Iain G Johnston; Joerg P Burgstaller
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 4.  Role of Mitochondria in Viral Infections.

Authors:  Srikanth Elesela; Nicholas W Lukacs
Journal:  Life (Basel)       Date:  2021-03-11

Review 5.  Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?

Authors:  Jesse D Moreira; Deepa M Gopal; Darrell N Kotton; Jessica L Fetterman
Journal:  Genes (Basel)       Date:  2021-10-22       Impact factor: 4.096

6.  Roles of the mitochondrial replisome in mitochondrial DNA deletion formation.

Authors:  Marcos T Oliveira; Carolina de Bovi Pontes; Grzegorz L Ciesielski
Journal:  Genet Mol Biol       Date:  2020-03-02       Impact factor: 1.771

7.  Regulation of Mother-to-Offspring Transmission of mtDNA Heteroplasmy.

Authors:  Ana Latorre-Pellicer; Ana Victoria Lechuga-Vieco; Iain G Johnston; Riikka H Hämäläinen; Juan Pellico; Raquel Justo-Méndez; Jose María Fernández-Toro; Cristina Clavería; Adela Guaras; Rocío Sierra; Jordi Llop; Miguel Torres; Luis Miguel Criado; Anu Suomalainen; Nick S Jones; Jesús Ruíz-Cabello; José Antonio Enríquez
Journal:  Cell Metab       Date:  2019-10-03       Impact factor: 27.287

8.  Mitochondrial DNA heteroplasmy is modulated during oocyte development propagating mutation transmission.

Authors:  Haixin Zhang; Marco Esposito; Mikael G Pezet; Juvid Aryaman; Wei Wei; Florian Klimm; Claudia Calabrese; Stephen P Burr; Carolina H Macabelli; Carlo Viscomi; Mitinori Saitou; Marcos R Chiaratti; James B Stewart; Nick Jones; Patrick F Chinnery
Journal:  Sci Adv       Date:  2021-12-08       Impact factor: 14.136

Review 9.  The role of mitophagy during oocyte aging in human, mouse, and Drosophila: implications for oocyte quality and mitochondrial disease.

Authors:  Rachel T Cox; Joanna Poulton; Suzannah A Williams
Journal:  Reprod Fertil       Date:  2021-10-11

Review 10.  Mitochondrial DNA disorders: from pathogenic variants to preventing transmission.

Authors:  Tiago M Bernardino Gomes; Yi Shiau Ng; Sarah J Pickett; Doug M Turnbull; Amy E Vincent
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.